Since the start of the pandemic, dermatologists have seen an average 50% drop in patient volume. While teledermatology has offered a channel for non-urgent patients and patient visits are rebounding, overall patient volumes are still significantly lower than 2019.
Esther Freeman, M.D., details the team effort made by the American Academy of Dermatology’s (AAD) COVID-19 Task Force to launch an international registry documenting skin manifestations in patients diagnosed with or suspected of COVID-19 infection.
A recent article suggests physicians should be on the lookout for various dermatologic manifestations in pediatric patients suspected of having COVID-19.
Vinod E. Nambudiri, M.D., MBA, breaks down tools the specialty can use to expand telehealth services to underserved communities.
What are some of the challenges of expanding teledermatology to underserved communities? Sepideh Ashrafzadeh answers this question in part four of our video interview.
In part three of our conversation, Sepideh Ashrafzadeh details sustainable steps the specialty can take to expand access to care to new and underserved communities during the current pandemic – and in the future.
In part two of our conversation on expanding care to underserved populations through telehealth, expert Vinod E. Nambudiri, M.D., MBA, dives into the disparities that most affect the specialty of dermatology.
Could the eased telehealth restrictions implemented in response to the COVID-19 pandemic allow for greater access to dermatologic care? We sat down with experts to explore how telehealth could be used to expand quality care to vulnerable and underserved populations across the United States.
Safety guidelines from the European Academy of Facial Plastic Surgery Aesthetic Medicine Focus Group describe protocols for protecting clinic staff and patients from COVID-19. Recommendations include procedures before, during and after a patient visit, as well as necessary forms.
Expert Christine Ko, M.D., FAAD, discusses case reports exploring the variability of skin manifestation in patients with or suspected of COVID-19 infection.